openPR Logo
Press release

Insulin Delivery Devices Market worth $48.93 billion by 2030, growing at a CAGR of 7.93% - Exclusive Report by 360iResearch

11-30-2023 10:06 AM CET | Health & Medicine

Press release from: 360iResearch

Insulin Delivery Devices Market | 360iResearch

Insulin Delivery Devices Market | 360iResearch

The "Insulin Delivery Devices Market by Product (Insulin Injectors, Insulin Pens, Insulin Pumps), End-User (Homecare, Hospitals) - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

The Global Insulin Delivery Devices Market to grow from USD 26.56 billion in 2022 to USD 48.93 billion by 2030, at a CAGR of 7.93%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/insulin-delivery-devices?utm_source=openpr&utm_medium=referral&utm_campaign=sample

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Insulin Delivery Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Insulin Delivery Devices Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Insulin Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc, Becton, Dickinson and Company, Biocon Ltd., Braun Melsungen AG, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Ltd., Dr Reddy's Laboratories Ltd, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Insulet Corporation, Johnson & Johnson, Medtronic PLC, Merck & Co., Inc., Novo Nordisk A/S, Sanofi SA, Tandem Diabetes Care, Inc., TOPAS Advanced Polymers GmbH, Ypsomed AG, and Zealand Pharma A/S.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/insulin-delivery-devices?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

Market Segmentation & Coverage:

This research report categorizes the Insulin Delivery Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Insulin Injectors, Insulin Pens, Insulin Pumps, and Insulin Syringes. The Insulin Injectors is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Homecare and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Insulin Delivery Devices Market, by Product
7. Insulin Delivery Devices Market, by End-User
8. Americas Insulin Delivery Devices Market
9. Asia-Pacific Insulin Delivery Devices Market
10. Europe, Middle East & Africa Insulin Delivery Devices Market
11. Competitive Landscape
12. Competitive Portfolio
13. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Insulin Delivery Devices Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Insulin Delivery Devices Market?
3. What is the competitive strategic window for opportunities in the Insulin Delivery Devices Market?
4. What are the technology trends and regulatory frameworks in the Insulin Delivery Devices Market?
5. What is the market share of the leading vendors in the Insulin Delivery Devices Market?
6. What modes and strategic moves are considered suitable for entering the Insulin Delivery Devices Market?

Read More @ https://www.360iresearch.com/library/intelligence/insulin-delivery-devices?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales"@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Delivery Devices Market worth $48.93 billion by 2030, growing at a CAGR of 7.93% - Exclusive Report by 360iResearch here

News-ID: 3310149 • Views:

More Releases from 360iResearch

Embedded Finance Market worth $228.79 billion by 2030, growing at a CAGR of 18.75% - Exclusive Report by 360iResearch
Embedded Finance Market worth $228.79 billion by 2030, growing at a CAGR of 18.7 …
The "Embedded Finance Market by Services (Embedded Banking Services, Embedded Insurance, Embedded Lending), Integration Type (Application Programming Interfaces, Software Development Kits), Business Model, End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/embedded-finance Embedded Finance refers to the integration of financial services, such as lending, insurance, payments, or banking, directly within the products or services of non-financial companies using Application Programming Interfaces (APIs).
Currency Management Market worth $1,305.97 billion by 2030, growing at a CAGR of 15.74% - Exclusive Report by 360iResearch
Currency Management Market worth $1,305.97 billion by 2030, growing at a CAGR of …
The "Currency Management Market by Offering (Services, Software), Type (Fixed Currency Exchange, Floating Currency Exchange), End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/currency-management Currency management encompasses strategies, methodologies, and tools employed by firms and financial institutions to address risks and potential benefits associated with currency fluctuations, involving activities such as hedging, arbitrage, and strategic investment planning to mitigate negative financial impacts
Bromacil Market worth $191.69 million by 2030, growing at a CAGR of 4.56% - Exclusive Report by 360iResearch
Bromacil Market worth $191.69 million by 2030, growing at a CAGR of 4.56% - Excl …
The "Bromacil Market by Formulation (Granular Formulation, Liquid Formulation), Distribution Channel (Offline, Online) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/bromacil Bromacil, a herbicide used to control broadleaf weeds and grasses, is vital for vegetation management in agricultural and non-cropland areas due to its soil-residual activity and efficacy in preventing weed growth, ultimately enhancing agricultural productivity and land utility. Applications span agricultural
Carbon Monoxide Market worth $7.92 billion by 2030, growing at a CAGR of 4.45% - Exclusive Report by 360iResearch
Carbon Monoxide Market worth $7.92 billion by 2030, growing at a CAGR of 4.45% - …
The "Carbon Monoxide Market by Purity Level (98% - 99%, Over 99%), Application (Chemical Synthesis, Food & Beverage, Fuel) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/carbon-monoxide The scope of carbon monoxide (CO) market research encompasses comprehensive evaluations of production, distribution, application, and end-use industries, providing insights into current market size, projected growth, and future demand across key regions such as North

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Bluetooth connected smart insulin pens represent the future of insulin delivery …
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development of ground-breaking products. Smart insulin pens are among such devices that have revolutionised the global market for diabetic injection pens. A recent study published by Future Market Insights projects that the global smart insulin pens market, which is currently valued at US$ 0.86 Mn, will expand vigorously at 17.9% CAGR through the
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin
Insulin Drug and Delivery Technologies Market Report 2018: Segmentation by Produ …
Global Insulin Drug and Delivery Technologies market research report provides company profile for Julphar, Ypsomed, Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
09-06-2017 | Health & Medicine
MRRSE
Smart Insulin Pens Market: Bluetooth Connected Smart Insulin Pens Allow Effectiv …
By connectivity, the Bluetooth connected smart insulin pen segment is expected to account for a value share of US$ 0.276 Mn in 2017. The segment is expected to reach a little more than US$ 2 Mn by 2027 end, registering the highest CAGR of 23.2% over the forecast period. Bluetooth connected smart insulin pens represent the future of insulin delivery devices. Such devices have an inbuilt Bluetooth connectivity feature allowing
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact